This 2025 BASHH guideline updates the 2018 UK national recommendations for the diagnosis, treatment, and health promotion principles needed for the effective management of infection with Neisseria gonorrhoeae.
Key Findings
Background
The 2025 guideline updates treatment recommendations for gonorrhoea reflecting changes in antimicrobial resistance patterns since the 2018 guideline.
The guideline is produced by the British Association of Sexual Health and HIV (BASHH)
It covers diagnosis, treatment, and health promotion principles for gonorrhoea management
It represents an update to the previous 2018 UK national guideline
The guideline addresses management of Neisseria gonorrhoeae infection specifically
Methods
The guideline provides updated recommendations on diagnosis of Neisseria gonorrhoeae infection.
Diagnostic recommendations are included as a core component of the guideline
The guideline covers effective management principles including diagnostic pathways
Updates reflect advances in diagnostic methods and surveillance data available since 2018
Results
The guideline provides updated treatment recommendations for gonorrhoea management in the UK.
Treatment recommendations are a central component of the updated 2025 guideline
Updates to treatment reflect evolving antimicrobial resistance in Neisseria gonorrhoeae
The guideline addresses health promotion principles alongside treatment recommendations
Authors include specialists in sexual health and HIV from multiple UK institutions
Conclusions
Health promotion principles are included as a core component of effective gonorrhoea management in the guideline.
Health promotion is listed alongside diagnosis and treatment as a necessary component of effective management
The guideline is intended to guide clinical practice across UK sexual health services
The multidisciplinary author group includes clinicians and public health specialists
What This Means
This research paper is a 2025 clinical practice guideline from the British Association of Sexual Health and HIV (BASHH) that provides updated national recommendations for how gonorrhoea should be diagnosed, treated, and managed across the United Kingdom. It updates the previous version of the guideline from 2018, reflecting new evidence, changes in antibiotic resistance patterns in the gonorrhoea bacteria (Neisseria gonorrhoeae), and advances in diagnostic approaches. The guideline covers not only clinical testing and treatment but also health promotion strategies to reduce transmission.
Gonorrhoea is one of the most common sexually transmitted infections in the UK and globally, and the bacteria that causes it has increasingly developed resistance to many of the antibiotics historically used to treat it. This research suggests that updated national guidance is necessary to ensure clinicians are using the most effective and appropriate current treatments, diagnostic tools, and patient management strategies to address this evolving public health challenge.
For people using sexual health services, this guideline informs the standards of care they can expect to receive in UK clinics. For healthcare providers, it offers a standardized, evidence-based framework to ensure consistent, up-to-date management of gonorrhoea across different settings. The inclusion of health promotion principles reflects the importance of prevention alongside treatment in controlling the spread of infection.
Fifer H, Ismail M, Soni S, Nwaosu U, Sadiq S, Milligan A, et al.. (2025). British Association of Sexual Health and HIV UK National Guideline for the Management of infection with Neisseria gonorrhoeae, 2025.. International journal of STD & AIDS. https://doi.org/10.1177/09564624251345195